← Leaderboards
Kwame Osei
Ohio State University
$754,133
Attributed
$754,133
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $16.6K · FY2005–08$20K$15K$10K$5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$754,133 · 10
By mechanism
M01$754,133 · 10
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Robert V Hoffman$182,152
- Dara P Schuster$993,474
- Charles G Orosz$3,562,189
- Daryl Cottrell$242,494
- Kathleen Marie Dungan$1,325,114
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectInsulinDiabetes Mellitus TherapyAfrican AmericanNoninsulin Dependent Diabetes MellitusBiomarkerChemopreventionInsulin Dependent Diabetes MellitusInsulin Sensitivity /ResistanceUnited States National Institutes Of HealthInstitutionResearch PersonnelResourcesFundingInsulin SensitivityGrantComputer Retrieval Of Information On Scientific Projects DatabaseSourceFamily GeneticsAmericanHypoglycemic AgentsAdiponectin
Grant awards (19)
EFFECTS OF RACE/ETHNICITY ON ADIPONECTIN LEVELS AND INSULIN ACTION$2,079
M01 · FY2008 · RR · contact PI
ADIPONECTIN IN PERSONS OF WEST AFRICAN ANCESTRY$693
M01 · FY2008 · RR · contact PI
GLUCOSE HOMEOSTASIS AND LIPID PATTERNS IN PATIENTS WITH TYPE 1 DIABETES 10 YEARS$15,409
M01 · FY2007 · RR · contact PI
ADIPONECTIN IN PERSONS OF WEST AFRICAN ANCESTRY$1,233
M01 · FY2007 · RR · contact PI
GLUCOSE HOMEOSTASIS AND LIPID PATTERNS IN PATIENTS WITH TYPE 1 DIABETES 10 YEARS$2,568
M01 · FY2006 · RR · contact PI
GLUCOSE HOMEOSTASIS AND LIPID PATTERNS IN PATIENTS WITH TYPE 1 DIABETES 10 YEARS$4,669
M01 · FY2005 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT-1)$193,916
M01 · FY2001 · RR
ANTIDIABETIC AGENTS AS PROPHYLAXIS IN PREVENTION OF NIDDM IN AFRICAN AMERICANS$193,916
M01 · FY2001 · RR
ENDOCRINE EVALUATION OF PANCREATIC TRANSPLANT$193,916
M01 · FY2001 · RR
ANTIDIABETIC AGENTS AS PROPHYLAXIS IN PREVENTION OF NIDDM IN AFRICAN AMERICANS$48,578
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT-1)$48,578
M01 · FY2000 · RR
ENDOCRINE EVALUATION OF PANCREATIC TRANSPLANT$48,578
M01 · FY2000 · RR
EFFICACY OF REPAGLINIDE ALONE AND/OR IN COMBINATION WITH METFORMIN$0
M01 · FY2000 · RR
EFFICACY OF REPAGLINIDE ALONE AND/OR IN COMBINATION WITH METFORMIN$0
M01 · FY2000 · RR
COMPARISON OF ONCE DAILY NN304 AND ONCE DAILY NPH INSULIN TREATMENT IN NIDDM$0
M01 · FY2000 · RR
COMPARISON OF ONCE DAILY NN304 AND ONCE DAILY NPH INSULIN TREATMENT IN NIDDM$0
M01 · FY2000 · RR
ENDOCRINE EVALUATION OF PANCREATIC TRANSPLANT$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT-1)$0
M01 · FY2000 · RR
ANTIDIABETIC AGENTS AS PROPHYLAXIS IN PREVENTION OF NIDDM IN AFRICAN AMERICANS$0
M01 · FY2000 · RR